Results of a BoNT/A Antibody Study in Children and Adolescents after Onabotulinumtoxin A (Botox®) Detrusor Injection

Publisher： Karger

E-ISSN： 1423-0399|87|4|434-438

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.87, Iss.4, 2011-09, pp. : 434-438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The need for better evidence for the use of Botulinum toxin A (BoNT‐A) in the treatment of children with CP: Lessons from Norway

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 58, Iss. S5, 2016-09 ,pp. : 27-27

John Wiley & Sons Inc

Access to resources Recommend Favorite

Submucosal Administration of OnabotulinumtoxinA in the Treatment of Neurogenic Detrusor Overactivity: Pilot Single-Centre Experience and Comparison with Standard Injection into the Detrusor

By  

Urologia Internationalis, Vol. 91, Iss. 4, 2013-06 ,pp. : 423-428

Karger

Access to resources Recommend Favorite

Injection Patterns of Onabotulinumtoxin A in Migraine Headache

By  

HEADACHE, Vol. 58, Iss. 1, 2018-01 ,pp. : 148-150

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urinary retention rates after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of this outcome

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 34, Iss. 7, 2015-09 ,pp. : 675-678

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of onabotulinumtoxinA injection in patients with refractory overactive bladder: First multicentric study in Turkish population

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 37, Iss. 1, 2018-01 ,pp. : 263-268

John Wiley & Sons Inc

Access to resources Recommend Favorite